46.95
BATS BZX Real-Time Price
As of 10:02am ET
 -0.31 / -0.66%
Today’s Change
37.62
Today|||52-Week Range
51.84
-6.47%
Year-to-Date
Sanofi to Sell Its 20.6% Stake in Regeneron, but Keep Their Collaboration Intact
May 26 / MotleyFool.com - Paid Partner Content
Should You Buy MyoKardia Stock After This Weeks 96% Gain?
May 16 / MotleyFool.com - Paid Partner Content
Does Novavax Have What It Takes to Win the COVID-19 Vaccine Race?
May 24 / MotleyFool.com - Paid Partner Content
Where Will Novavax Be in 1 Year?
May 16 / MotleyFool.com - Paid Partner Content
Better Buy: GlaxoSmithKline vs. Pfizer
May 20 / MotleyFool.com - Paid Partner Content
Trump Taps Former GlaxoSmithKline Exec For 'Warp Speed' COVID-19 Vaccine Initiative
May 15 / MotleyFool.com - Paid Partner Content
Is Buying a Basket Loaded With Every Coronavirus Vaccine Stock a Smart Strategy?
May 17 / MotleyFool.com - Paid Partner Content
France piles pressure on Sanofi over coronavirus vaccine plans
May 15 / CNN.com - Paid Partner Content
Moderna and Novavax are Making Strides in Advancing Novel Coronavirus Vaccine Research
May 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close47.26
Today’s open47.21
Day’s range46.78 - 47.23
Volume17,716
Average volume (3 months)2,454,147
Market cap$118.6B
Data as of 10:05am ET, 05/27/2020

Growth & Valuation

Earnings growth (last year)-38.50%
Earnings growth (this year)+3.50%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-0.55%
P/E ratio37.0
Price/Sales3.10
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-1.11-1.75%
GSKGlaxoSmithKline-0.13-0.32%
BMYBristol-Myers Squibb-0.51-0.85%
AZNAstraZeneca-1.59-2.99%
Data as of 10:05am ET, 05/27/2020

Financials

Last reporting date--
EPS forecast (this quarter)$0.71
Annual revenue (last year)$40.4B
Annual profit (last year)$3.1B
Net profit margin8.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Paris, Ile-de-france

Forecasts